Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agenus Inc (NQ: AGEN )

2.810 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EST, Nov 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 809
Open 2.810
Bid (Size) 2.800 (2)
Ask (Size) 2.810 (2)
Prev. Close 2.810
Today's Range 2.810 - 2.810
52wk Range 1.250 - 3.620
Shares Outstanding 304,811,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
From Agenus Inc.
Via Globe NewsWire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
From Agenus Inc.
Via Globe NewsWire

Performance

YTD
-19.02%
-19.02%
1 Month
+10.20%
+10.20%
3 Month
+5.64%
+5.64%
6 Month
+68.26%
+68.26%
1 Year
-10.79%
-10.79%

More News

Read More
Miniso Group, Monday.com And Other Big Gainers From Monday
Via Benzinga
Agenus (AGEN) Q3 2022 Earnings Call Transcript
Via The Motley Fool
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Agenus Stock Rose 18.4% on Thursday
Via The Motley Fool
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
From Agenus Inc.
Via Globe NewsWire
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
10 Best Medical Stocks Under $5
Via Talk Markets
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
From Agenus Inc.
Via Globe NewsWire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
From Agenus Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
From Agenus Inc.
Via Globe NewsWire
Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Agenus Inc.
Via Globe NewsWire
7 Penny Stocks That Actually Have a Buy Rating
Via InvestorPlace
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
Via Benzinga
Agenus Earnings Perspective: Return On Capital Employed
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.